Clinical Trial Update: A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment

View source ↗

Summary

This clinical trial update describes a perspective study evaluating MRD-tailored therapy for patients with newly diagnosed multiple myeloma who have persistent …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: FengYan Jin | Conditions: Multiple Myeloma, Minimal Residual Disease | Status: RECRUITING